The high nAR expression (activation form) and its splice variant AR-V7 have been shown to be associated with poor BCR-free survival in patients with PCa who underwent RP with and without neoadjuvant therapy [38, 39]. This evidence concerns the gene BCR and posterior cortical atrophy.